J1364 HCPCS Level II code: Injection, erythromycin lactobionate, per 500 mg
J1364 is the HCPCS code for “Injection, erythromycin lactobionate, per 500 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1364Injection, erythromycin lactobionate, per 500 mg
Short description: Erythro lactobionate /500 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J1364 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1995
Where J1364 sits
- 1J codesDrugs administered other than orally
- 2Active code J1364Injection, erythromycin lactobionate, per 500 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1364 mean?
J1364 is the HCPCS code for “Injection, erythromycin lactobionate, per 500 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1364?
CMS lists J1364’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1364
All J codesJ1324Injection, enfuvirtide, 1 mgJ1325Injection, epoprostenol, 0.5 mgJ1326Injection, zolbetuximab-clzb, 2 mgJ1327Injection, eptifibatide, 5 mgJ1330Injection, ergonovine maleate, up to 0.2 mgJ1335Injection, ertapenem sodium, 500 mgJ1370Injection, esomeprazole sodium, 1 mgJ1380Injection, estradiol valerate, up to 10 mgJ1410Injection, estrogen conjugated, per 25 mgJ1411Injection, etranacogene dezaparvovec-drlb, per therapeutic doseJ1412Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomesJ1413Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose